Graves v. Bayer Pharma AG et al
Beverly Graves |
Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson, Bayer Corporation and Bayer Pharma AG |
4:2019cv00042 |
February 4, 2019 |
US District Court for the Southern District of Iowa |
Celeste F Bremer |
Stephanie M Rose |
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
28 U.S.C. ยง 1407 pl |
Both |
Docket Report
This docket was last retrieved on February 21, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 8 Certified Conditional Transfer Order 184 by Clerk's Office, Eastern District of Louisiana. (slg) |
***Civil Case Terminated. Electronically sent to Eastern District of Louisiana. (slg) |
Filing 7 Certified Conditional Transfer Order MDL No. 2592 for Eastern District of Louisiana. (slg) |
Filing 6 TEXT MINUTE ORDER - TO INVOLVED CLERKS - Conditional Transfer Order (CTO-184) Finalized on 2/14/19. Please see pleading (3 in IAS/4:19-cv-00042, 1496 in MDL No. 2592).As stipulated in Rule 7.1(c) of the Rules of Procedure of the Judicial Panel on Multidistrict Litigation, transmittal of the order has been stayed 7 days to give any party an opportunity to oppose the transfer.The 7-day period has now elapsed, no opposition was received, and the order is directed to the Clerk of the United States District Court for the E.D. Louisiana for filing. The Panel governing statute, 28 U.S.C. 1407, requires that the transferee clerk transmit a certified copy of the Panel order to transfer to the clerk of the district court from which the action is being transferred.Signed by Clerk of the Panel Jeffery N. Luthi on 2/14/2019. Associated Cases: MDL No. 2592, IAS/4:19-cv-00042 (DP) (slg) |
Filing 5 TEXT ORDER granting #4 all Defendants unresisted Motion for Extension of Time to and including March 11, 2019, to move or plead. Signed by Magistrate Judge Celeste F. Bremer on 2/6/2019. (mlr) |
Filing 4 Consent MOTION for Extension of Time to File Answer re #1 Notice of Removal,, by Bayer Corporation, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Janssen Research & Development, LLC, Johnson & Johnson.Motions referred to Celeste F. Bremer. (Hardeman, Kimberly) |
Filing 3 Letter to MDL Panel regarding Potential Tag-Along Action. Paperwork emailed to MDL Panel. (kjw) |
Filing 2 Corporate Disclosure/Statement of Interest by Bayer Corporation, Bayer Pharma AG. (Hardeman, Kimberly) |
Filing 1 NOTICE OF REMOVAL by Bayer Corporation, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Johnson & Johnson Pharmaceutical Research and Development from Marion County, case number LACV096890. Filing fee paid in the amount of $ 400, receipt number 0863-3720784., filed by Bayer Corporation, Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Johnson & Johnson Pharmaceutical Research and Development. Rule 16 Notice of Dismissal set for 5/6/2019. (Attachments: #1 Civil Cover Sheet, #2 State Court Pleadings, #3 Rule 7.1 Corporate Disclosure Statement)(Hardeman, Kimberly) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Iowa Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.